MED 6037- Glucose and Ketone Testing at Point of Care

The University Hospitals of North Midlands NHS Trust has awarded a contract for the purchase of glucose and ketone testing at point of care. Located in Stoke on Trent, the procurement process was conducted using an open procedure. The industry category is focused on goods and laboratory diagnostics.

The official contract award date was 28 October 2025, with the contract period set to start on 1 April 2026 and expected to end on 31 March 2030, having potential extensions up to March 2032. The award notice identifies Roche Diagnostics Ltd as the supplier, with a contract value amounting to £2,100,000. This procurement process covers multiple regions within the UK and involves significant public authority investment, reflecting the importance of advanced healthcare solutions.

This tender presents substantial opportunities for businesses in the medical diagnostics and healthcare technology sectors. Large-scale suppliers specialising in diagnostic devices and pathology services would find this contract particularly lucrative due to the high-value nature and extended duration of the agreement. The open procurement approach ensures competitive pricing and high-quality service delivery, urging businesses to propose innovative solutions to meet the NHS Trust's healthcare needs.

Such contracts play a pivotal role in propelling business growth by enabling companies to showcase their expertise in delivering essential healthcare services across different regions of the United Kingdom.